David Juhl

Evaluation of pretest clinical score (4 T's) for the diagnosis of heparin‐induced thrombocytopenia in two clinical settings

Gregory Lo, David Juhl, Theodore E. Warkentin et al. · Journal of Thrombosis and Haemostasis · 2006 · 987 citations · Full text

Clinical Settings, Thrombosis, Heparin‐induced Thrombocytopenia +8

Heparin‐induced thrombocytopenia: a prospective study on the incidence, platelet‐activating capacity and clinical significance of antiplatelet factor 4/heparin antibodies of the IgG, IgM, and IgA classes

Andreas Greinacher, David Juhl, Ulrike Strobel et al. · Journal of Thrombosis and Haemostasis · 2007 · 231 citations

Thrombosis, Allergy, Autoimmune Disease +9

Incidence and clinical significance of anti‐PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin‐induced thrombocytopenia

David Juhl, Petra Eichler, Norbert Lübenow et al. · European Journal Of Haematology · 2006 · 167 citations

Seroprevalence and incidence of hepatitis <scp>E</scp> virus infection in <scp>G</scp>erman blood donors

David Juhl, Sally A. Baylis, Johannes Blümel et al. · Transfusion · 2013 · 120 citations

Positive impact of Platelet-rich plasma and Platelet-rich fibrin on viability, migration and proliferation of osteoblasts and fibroblasts treated with zoledronic acid

Daniel Steller, Nele Herbst, Ralph Pries et al. · Scientific Reports · 2019 · 61 citations · Full text